![An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The](https://jcadonline.com/wp-content/uploads/September2020PanchaprateepFigure2.jpg)
An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The
![Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41702-019-0046-y/MediaObjects/41702_2019_46_Fig2_HTML.png)
Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text
![Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology](https://onlinelibrary.wiley.com/cms/asset/fec1e2e8-1746-4367-ab4d-0b1d79098e29/jdv17623-fig-0001-m.jpg)
Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology
![Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/88/3/173/F2.large.jpg)
Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine
Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women - FullText - Skin Appendage Disorders 2020, Vol. 6, No. 3 - Karger Publishers
![Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine Male and female pattern hair loss: Treatable and worth treating | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/88/3/173/F3.large.jpg)